These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15967058)

  • 21. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study.
    Brezo J; Bureau A; Mérette C; Jomphe V; Barker ED; Vitaro F; Hébert M; Carbonneau R; Tremblay RE; Turecki G
    Mol Psychiatry; 2010 Aug; 15(8):831-43. PubMed ID: 19381154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family history of suicidal behavior and mood disorders in probands with mood disorders.
    Mann JJ; Bortinger J; Oquendo MA; Currier D; Li S; Brent DA
    Am J Psychiatry; 2005 Sep; 162(9):1672-9. PubMed ID: 16135627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suicide risk in mood disorders.
    Rihmer Z
    Curr Opin Psychiatry; 2007 Jan; 20(1):17-22. PubMed ID: 17143077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mood disorders and suicide.
    Nierenberg AA; Gray SM; Grandin LD
    J Clin Psychiatry; 2001; 62 Suppl 25():27-30. PubMed ID: 11765092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder.
    Coryell W; Young E; Carroll B
    Psychiatry Res; 2006 May; 142(1):99-104. PubMed ID: 16631257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function.
    Sullivan GM; Mann JJ; Oquendo MA; Lo ES; Cooper TB; Gorman JM
    Biol Psychiatry; 2006 Sep; 60(5):500-6. PubMed ID: 16487493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress system alterations and mood disorders in suicidal patients. A review.
    Westrin A
    Biomed Pharmacother; 2000 Apr; 54(3):142-5. PubMed ID: 10840591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dexamethasone suppression test in children and adolescents with major depressive disorder: a review.
    Casat CD; Powell K
    J Clin Psychiatry; 1988 Oct; 49(10):390-3. PubMed ID: 3049559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol, CSF 5-HIAA, violence and intent in suicidal men.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2010 Jun; 178(1):217-9. PubMed ID: 20452040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suicide and the dexamethasone suppression test in unipolar depression.
    Coryell W; Schlesser MA
    Am J Psychiatry; 1981 Aug; 138(8):1120-1. PubMed ID: 7258395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
    Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
    Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis.
    Schade RP; Schinkel J; Roelandse FW; Geskus RB; Visser LG; van Dijk JM; Voormolen JH; Van Pelt H; Kuijper EJ
    J Neurosurg; 2006 Jan; 104(1):101-8. PubMed ID: 16509153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry.
    Arana GW; Mossman D
    Neurol Clin; 1988 Feb; 6(1):21-39. PubMed ID: 2837633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inadequate response to therapy as a predictor of suicide.
    Dahlsgaard KK; Beck AT; Brown GK
    Suicide Life Threat Behav; 1998; 28(2):197-204. PubMed ID: 9674079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The Relationship of Suicide Attempts with Affective Temperament and Relevant Clinical Features in Patients with Mood Disorders].
    Ekşioğlu S; Güleç H; Şimşek G; Semiz ÜB
    Turk Psikiyatri Derg; 2015; 26(2):99-106. PubMed ID: 26111285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma.
    Eller-Vainicher C; Morelli V; Salcuni AS; Battista C; Torlontano M; Coletti F; Iorio L; Cairoli E; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A; Chiodini I
    Eur J Endocrinol; 2010 Dec; 163(6):925-35. PubMed ID: 20881060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical applications of the dexamethasone suppression test for endogenous depression.
    Carroll BJ
    Pharmacopsychiatria; 1982 Jan; 15(1):19-25. PubMed ID: 7038718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suicidal behaviors and personality structure.
    Grava G; Ceroni GB; Rucci P; Scudellari P
    Suicide Life Threat Behav; 2006 Oct; 36(5):569-77. PubMed ID: 17087635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.